Verily nets irregular pulse clearance for its clinical study smartwatch

One year after receiving its first FDA clearance bringing electrocardiogram capabilities to its prescription-only smartwatch designed for clinical studies, Verily has obtained a second agency green light for measuring irregular heartbeats.

Sourced through Scoop.it from: www.fiercebiotech.com